Oncolytic Viro-Immuno Therapy Cancer Treatment

A New Era in Cancer Treatment

We assist and accompany cancer patients to travel overseas for Oncolytic Viro-Immuno Therapy and facilitate the whole process.

What is Cancer Oncolytic Viro-Immuno Therapy?

Oncolytic Viro-Immuno Therapy specifically destroys cancer cells using a virus.  This virus is the world’s first clinically approved and registered oncolytic virus which is not genetically modified. This treatment is based on more than 50 years of research.

Oncolytic Viro-Immuno Therapy takes place at a Cancer Clinic overseas, based on the patient’s individual needs.  The virus is administered by both an Oncologist as well as an Immunologist while the patient is there, with follow ups in South Africa.

Effectiveness

Oncolytic Viro-Immuno Therapy effectiveness is recognised as a safe and effective cancer treatment

Oncolytic Viro-Immuno Therapy effectiveness has been proven over many years of clinical studies.  In 2015, the medical journal Melanoma Research published a study that revealed that melanoma patients treated with Oncolytic Viro-Immuno Therapy are 4 to 6 times more likely to survive than those who did not receive it. Oncolytic Viro-Immuno Therapy is also used off label to treat solid tumors ( organs and tissues ) with a 14 year track record of safety and efficacy.

Mode of Action

The virus finds and infects tumour cells.  This process is called oncotropism.  Subsequently, the virus replicates within the tumour cells and destroys them.  This process is called oncolysis.  Both processes are selective for tumour cells and normal healthy cells are minimally affected, if at all.

Welcome To Your Health!

Along with Oxygen based therapies, dietary changes and nutritional support, Specialised IV Infusions and Oncolytic Viro-Immuno Therapy, we offer this treatment plan to those who cannot have traditional cancer treatments such as surgery chemotherapy and radiation, if required, or who have already been treated but treatment has failed.

On average, treatment takes place for 5 days overseas, with further follow ups ( 3 – 6 months ) in Johannesburg or Pretoria, including blood tests and scans which are reviewed by our Medical Team and sent overseas to our colleagues for monitoring and evaluation.

share